Abstract

INTRODUCTION:Diabetes Mellitus(DM) is a major risk factor for cardiovascular diseases, including ischemic heart disease (IHD), and significantly increases the risk of cardiovascular mortality and morbidity,compared to non-diabetics. Early detection of Asymtomatic (Silent) myocardial ischemia in diabetics,may prevent cardiovascular morbidity and mortality with timely intervention.Non-invasive tests like the Treadmill Test are cost-effective, widely available, and useful for early detection of coronary artery disease in high-risk patients. AIM:To assess the prevalence and clinical predictors of silent myocardial ischemia in patients with Type 2 Diabetes Mellitus using Treadmill test. METHODOLOGY:This was a cross-sectional study conducted in the Department of Medicine, SMS Hospital, Jaipur. The study took place from April 2023 for a duration of one year, or until the required sample size was achieved, with an additional two months allocated for data compilation and analysis.RESULT:In this study, factors like older age, longer duration of diabetes, higher BMI, elevated HbA1c, cholesterol, and triglycerides were significantly associated with positive TMT results, indicating increased cardiovascular risk. Additionally, microalbuminuria and macroalbuminuria were strongly linked to inducible ischemia, highlighting their role in CAD risk.CONCLUSION:In conclusion, TMT is an effective screening tool for early detection of silent myocardial ischemia in T2DM patients, aiding in the identification of those at risk for CAD.

Description

.